A detailed history of Charles Schwab Investment Management Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 145,332 shares of NKTX stock, worth $656,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,332
Previous 89,428 62.51%
Holding current value
$656,900
Previous $966,000 11.18%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$5.27 - $10.82 $294,614 - $604,881
55,904 Added 62.51%
145,332 $858,000
Q1 2024

May 08, 2024

BUY
$5.59 - $15.71 $113,583 - $319,211
20,319 Added 29.4%
89,428 $966,000
Q3 2023

Nov 08, 2023

SELL
$1.39 - $2.29 $241,481 - $397,837
-173,728 Reduced 71.54%
69,109 $96,000
Q2 2023

Aug 09, 2023

BUY
$2.19 - $5.17 $5,490 - $12,961
2,507 Added 1.04%
242,837 $531,000
Q1 2023

May 11, 2023

SELL
$3.37 - $6.3 $41,700 - $77,956
-12,374 Reduced 4.9%
240,330 $853,000
Q4 2022

Feb 13, 2023

BUY
$5.14 - $14.35 $23,746 - $66,297
4,620 Added 1.86%
252,704 $1.51 Million
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $471,487 - $706,654
38,426 Added 18.33%
248,084 $3.27 Million
Q2 2022

Aug 15, 2022

BUY
$7.77 - $19.44 $891,661 - $2.23 Million
114,757 Added 120.92%
209,658 $2.58 Million
Q1 2022

May 13, 2022

SELL
$8.66 - $14.99 $54,445 - $94,242
-6,287 Reduced 6.21%
94,901 $1.08 Million
Q4 2021

Feb 11, 2022

BUY
$12.79 - $26.88 $39,840 - $83,731
3,115 Added 3.18%
101,188 $1.55 Million
Q3 2021

Nov 16, 2021

SELL
$26.67 - $38.76 $254,485 - $369,847
-9,542 Reduced 8.87%
98,073 $2.73 Million
Q2 2021

Aug 16, 2021

SELL
$23.94 - $36.68 $274,879 - $421,159
-11,482 Reduced 9.64%
107,615 $3.41 Million
Q1 2021

May 17, 2021

BUY
$31.33 - $59.61 $360,451 - $685,813
11,505 Added 10.69%
119,097 $3.92 Million
Q4 2020

Feb 16, 2021

BUY
$27.03 - $75.62 $36,544 - $102,238
1,352 Added 1.27%
107,592 $6.61 Million
Q3 2020

Nov 13, 2020

BUY
$23.52 - $47.9 $2.5 Million - $5.09 Million
106,240 New
106,240 $3.19 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $220M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.